Guidance Change and Earnings Put Henry Schein in Focus

Henry Schein (HSIC) raised its 2026 sales growth outlook to a range of 4.5% to 5.5%, alongside second quarter results showing higher sales, net income, and earnings per share compared with the prior year period.

Henry Schein’s recent guidance increase and earnings report come alongside a 27.08% 3 month share price return and a 33.33% 1 year total shareholder return. This signals building momentum around the stock at the current US$88.13 share price.

If you are looking beyond Henry Schein for other ideas in health focused technology, this is a good moment to review 43 healthcare AI stocks.

The latest guidance lift, stronger recent results, and a 33.33% 1 year total return leave Henry Schein looking more expensive than it did a few months ago. Does the current valuation still offer a favourable trade off for new buyers?

Most Popular Narrative: 10% Overvalued

The most followed narrative for Henry Schein estimates a fair value of $88.07, which sits slightly below the current $88.13 share price and frames a relatively full valuation.

The analysts have a consensus price target of $88.07 for Henry Schein based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $100.0, and the most bearish reporting a price target of just $64.0.

Curious what sits behind that tight gap between price and fair value? The narrative relies on gradual revenue growth, firming margins, and a reset earnings multiple. The key assumptions are all on the table, but the numbers themselves are where the real story starts.

Result: Fair Value of $88.07 (ABOUT RIGHT)

However, investors still need to watch for ongoing pricing pressure in core distribution and any slowdown in dental patient traffic, which could challenge the Henry Schein narrative.

Another View on Henry Schein’s Valuation

While analyst targets cluster around a fair value of about $88 per share, the Simply Wall St DCF model points in a different direction. It values Henry Schein at $161.73 per share, which sits well above the current $88.13 price. Which set of assumptions do you find more reasonable?

Next Steps

Mixed signals around Henry Schein’s valuation and outlook can feel unclear, so it helps to see both sides and decide quickly where you stand. To weigh the potential upside against the concerns flagged by other investors, take a closer look at the 2 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Henry Schein?

If you stop at Henry Schein, you could miss other stocks that fit your goals. Use this moment to widen your watchlist with focused, data driven ideas.

• Target income potential by reviewing carefully selected companies in the 8 dividend fortresses that could support a steadier cash flow profile.
• Hunt for quality at a reasonable price by scanning the screener containing 21 high quality undiscovered gems that may sit off most investors’ radar.
• Prioritise resilience by focusing on companies in the 83 resilient stocks with low risk scores that score well on stability and downside protection.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.